ASXL2 antibody
Principal name
ASXL2 antibody
Alternative names for ASXL2 antibody
ASXH2, KIAA1685, Putative Polycomb group protein ASXL2, Additional sex combs-like protein 2
Ncbi ID
9606, NP_060733, NP_060733.4, NP_766009.2, NM_172421, NM_018263
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Immunoprecipitation (IP)
Background of ASXL2 antibody
- Kit Component:
- - KN301705G1, Asxl2 gRNA vector 1 in pCas-Guide vector
- KN301705G2, Asxl2 gRNA vector 2 in pCas-Guide vector
- KN301705D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual

Immunofluorescence of purified MaxPab antibody to ASXL2 on HeLa cell. [antibody concentration 10 ug/ml]

Western Blot analysis of ASXL2 expression in transfected 293T cell line by ASXL2 MaxPab polyclonal antibody.Lane 1: ASXL2 transfected lysate(100.98 KDa).Lane 2: Non-transfected lysate.
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC220364L2V | Lenti ORF particles, ASXL2 (mGFP-tagged) - Human additional sex combs like 2 (Drosophila) (ASXL2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€2,680.00
|
|
| OriGene Technologies, Inc. | ||
| RC220364L1V | Lenti ORF particles, ASXL2 (Myc-DDK tagged) - Human additional sex combs like 2 (Drosophila) (ASXL2) , 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€2,420.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR216546L2V | Lenti ORF particles, Asxl2 (GFP-tagged) - Mouse additional sex combs like 2 (Drosophila) (Asxl2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€2,410.00
|
|
| OriGene Technologies, Inc. | ||
| MR216546L1V | Lenti ORF particles, Asxl2 (Myc-DDK-tagged) - Mouse additional sex combs like 2 (Drosophila) (Asxl2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€2,180.00
|
|
| OriGene Technologies, Inc. | ||

